Filings

5 documents · 8 matches

1. LGND LIGAND PHARMACEUTICALS INC 8-K/A 2026-09-02

   share repurchases after December 31, 2022. The tax applies if the aggregate fair market value of repurchased stock during the taxable
   2 matches in this document Show context Copy citation

2. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-08-06

   count following the Company’s share repurchase in connection with the convertible debt financing. Ligand continues to expect the following:
   1 match in this document Show context Copy citation

3. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-06-25

   spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common stock upon conversion of the notes
   2 matches in this document Show context Copy citation

4. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-06-25

   spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common stock upon conversion of the notes
   1 match in this document Show context Copy citation

5. LGND LIGAND PHARMACEUTICALS INC 8-K 2026-06-22

   spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common stock upon conversion of the notes
   2 matches in this document Show context Copy citation